Related Experiment Video
Updated: Jun 8, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
PTPD1 supports receptor stability and mitogenic signaling in bladder cancer cells
Annalisa Carlucci1, Monia Porpora, Corrado Garbi
1Dipartimento di Biologia e Patologia Molecolare e Cellulare, Università Federico II, Naples, Italy.
Abstract:
PTPD1, a cytosolic non-receptor protein-tyrosine phosphatase, stimulates the Src-EGF transduction pathway. Localization of PTPD1 at actin cytoskeleton and adhesion sites is required for cell scattering and migration. Here, we show that during EGF stimulation, PTPD1 is rapidly recruited to endocytic vesicles containing the EGF receptor. Endosomal localization of PTPD1 is mediated by interaction with KIF16B, an endosomal kinesin that modulates receptor recycling at the plasma membrane. Silencing of PTPD1 promotes degradation of EGF receptor and inhibits downstream ERK signaling. We also found that PTPD1 is markedly increased in bladder cancer tissue samples. PTPD1 levels positively correlated with the grading and invasiveness potential of these tumors. Transgenic expression of an inactive PTPD1 mutant or genetic knockdown of the endogenous PTPD1 severely inhibited both growth and motility of human bladder cancer cells. These findings identify PTPD1 as a novel component of the endocytic machinery that impacts on EGF receptor stability and on growth and motility of bladder cancer cells.
Insights
Protein tyrosine phosphatase PTPD1 regulates EGF receptor stability and signaling. PTPD1 is crucial for bladder cancer cell growth and migration, making it a potential therapeutic target.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- PTPD1 (protein-tyrosine phosphatase 1) is a cytosolic phosphatase involved in cell signaling.
- Its role in actin cytoskeleton and adhesion sites is linked to cell migration.
- The epidermal growth factor receptor (EGFR) pathway is critical in cell growth and cancer.
Purpose of the Study:
- To investigate the role of PTPD1 in EGFR trafficking and signaling.
- To determine the involvement of PTPD1 in bladder cancer progression.
- To identify PTPD1 as a potential therapeutic target in bladder cancer.
Main Methods:
- Immunofluorescence microscopy to track PTPD1 localization.
- Co-immunoprecipitation assays to study protein interactions.
- Western blotting to assess protein levels and signaling pathways.
- Cell viability and migration assays.
- Analysis of human bladder cancer tissue samples.
Main Results:
- PTPD1 is recruited to endocytic vesicles containing EGFR upon EGF stimulation.
- PTPD1 interacts with KIF16B, an endosomal kinesin, influencing EGFR recycling.
- PTPD1 silencing leads to EGFR degradation and inhibited ERK signaling.
- Elevated PTPD1 levels correlate with increased tumor grade and invasiveness in bladder cancer.
- Inhibition of PTPD1 function significantly reduces bladder cancer cell growth and motility.
Conclusions:
- PTPD1 is a novel component of the endocytic machinery regulating EGFR stability.
- PTPD1 plays a significant role in bladder cancer cell growth and migration.
- PTPD1 represents a promising therapeutic target for bladder cancer treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Mitogens and the Cell Cycle
Intracellular Signaling Affects Focal Adhesions
Some...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
